Increased rates of HIF-1α synthesis in colon, gastric, lung, skin, ovarian, pancreatic and prostate gland carcinomas have been shown to correlate with tumor proliferation rates, malignancy grade and therapy resistance, and, ultimately, with adverse outcomes10,11. The gene discussed is HIF1A; the disease is neoplasm.